Combat Methamphetamine Enhancement Act of 2010

Public Law 111-203, H.R. 4173- Dodd-Frank Wall Street Reform and Consumer Protection Act. Issue: Implementation and Regulatory reform. Captive Reinsurance Transactions, Insurance Capital Standards and Global Capital Standards. Implementation of S. 2270 - Insurance Capital Standards Clarification Act of 2014. The bill would give the Federal Reserve the authority to tailor capital standards for insurance companies subject to Fed supervision. Issue: Capital Standards, Basel III Implementation of H.R. 748 - the Coronavirus Aid, Relief, and Economic Security (CARES) Act. This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. Issue: CECL, TDR, Remote Online Notarization, SBA loans. H.R. 2923/S. 1384 - Living Donor Protection Act. The bill would promote and protect from discrimination living organ donors. Issue: underwriting. H.R. 5535 - Insurance Data Protection Act. The bill would prohibit the Federal Insurance Office of the Department of the Treasury and other financial regulators from collecting data directly from an insurance company. Issue: Federal Insurance Office. H.R. 7000 and S. 3592 - Business of Insurance Regulatory Reform Act of 2024 - To amend the Consumer Financial Protection Act of 2010 to clarify the authority of the Bureau of Consumer Financial Protection with respect to persons regulated by a State insurance regulator. Issue: Business of Insurance. Issue: private equitys growing role in the insurance industry. Issue: S&P proposal on the methodology that is used to rate insurance companies. Issue: Russian sanctions legislation. Issue: Request for information from Congress regarding the diversity and inclusion information in the insurance industry. Issue: National Association of Registered Agents and Brokers (NARAB) board. No bill number assigned. Issue: Housing Finance Reform. No bill number assigned. Issue: Final margin rules for uncleared swaps transactions with respect to seeded investment funds. No bill number assigned.

Client expense: $1,042,541 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

INS - Quarter 4 2023 Public Law 111-203, H.R. 4173- Dodd-Frank Wall Street Reform and Consumer Protection Act. Issue: Implementation and Regulatory reform. Insurance Capital Standards and Global Capital Standards. Implementation of S. 2270 - Insurance Capital Standards Clarification Act of 2014. The bill would give the Federal Reserve the authority to tailor capital standards for insurance companies subject to Fed supervision. Issue: Capital Standards, Basel III Endgame Implementation of H.R. 748 - the Coronavirus Aid, Relief, and Economic Security (CARES) Act. This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. Issue: Remote Online Notarization H.R. 2923/S. 1384 - Living Donor Protection Act. The bill would promote and protect from discrimination living organ donors. Issue: underwriting. Issue: private equitys growing role in the insurance industry. Issue: S&P proposal on the methodology that is used to rate insurance companies. Issue: Request for information from Congress regarding the diversity and inclusion information in the insurance industry. Issue: Housing Finance Reform. No bill number assigned.

Client expense: $900,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-203, H.R. 4173- Dodd-Frank Wall Street Reform and Consumer Protection Act. Issue: Implementation and Regulatory reform. Captive Reinsurance Transactions, Insurance Capital Standards and Global Capital Standards. Implementation of S. 2270 - Insurance Capital Standards Clarification Act of 2014. The bill would give the Federal Reserve the authority to tailor capital standards for insurance companies subject to Fed supervision. Issue: Capital Standards, Basel III Implementation of H.R. 748 - the Coronavirus Aid, Relief, and Economic Security (CARES) Act. This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. Issue: CECL, TDR, Remote Online Notarization, SBA loans. H.R. 2923/S. 1384 - Living Donor Protection Act. The bill would promote and protect from discrimination living organ donors. Issue: underwriting. H.R. 5535 - Insurance Data Protection Act. The bill would prohibit the Federal Insurance Office of the Department of the Treasury and other financial regulators from collecting data directly from an insurance company. Issue: Federal Insurance Office. H.R.__S.__ - CFPB Business of Insurance Act. No bill number assigned. Issue: private equitys growing role in the insurance industry. Issue: S&P proposal on the methodology that is used to rate insurance companies. Issue: Russian sanctions legislation. Issue: Request for information from Congress regarding the diversity and inclusion information in the insurance industry. Issue: National Association of Registered Agents and Brokers (NARAB) board. No bill number assigned. Issue: Housing Finance Reform. No bill number assigned. Issue: Final margin rules for uncleared swaps transactions with respect to seeded investment funds. No bill number assigned.

Client expense: $1,035,678 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

INS - Quarter 3 2023 Public Law 111-203, H.R. 4173- Dodd-Frank Wall Street Reform and Consumer Protection Act. Issue: Implementation and Regulatory reform. Captive Reinsurance Transactions, Insurance Capital Standards and Global Capital Standards. Implementation of S. 2270 - Insurance Capital Standards Clarification Act of 2014. The bill would give the Federal Reserve the authority to tailor capital standards for insurance companies subject to Fed supervision. Issue: Capital Standards, Basel III H.R. 2923/S. 1384 - Living Donor Protection Act. The bill would promote and protect from discrimination living organ donors. Issue: underwriting. Issue: private equitys growing role in the insurance industry. Issue: S&P proposal on the methodology that is used to rate insurance companies. Issue: Housing Finance Reform. No bill number assigned.

Client expense: $780,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-203, H.R. 4173- Dodd-Frank Wall Street Reform and Consumer Protection Act. Issue: Implementation and Regulatory reform. Captive Reinsurance Transactions, Insurance Capital Standards and Global Capital Standards. Implementation of S. 2270 - Insurance Capital Standards Clarification Act of 2014. The bill would give the Federal Reserve the authority to tailor capital standards for insurance companies subject to Fed supervision. Issue: Capital Standards, Basel III Implementation of H.R. 748 - the Coronavirus Aid, Relief, and Economic Security (CARES) Act. This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. Issue: CECL, TDR, Remote Online Notarization, SBA loans. H.R. 2923/S. 1384 - Living Donor Protection Act. The bill would promote and protect from discrimination living organ donors. Issue: underwriting. H.R. 5535 - Insurance Data Protection Act. The bill would prohibit the Federal Insurance Office of the Department of the Treasury and other financial regulators from collecting data directly from an insurance company. Issue: Federal Insurance Office. H.R.__S.__ - CFPB Business of Insurance Act. No bill number assigned. Issue: private equitys growing role in the insurance industry. Issue: S&P proposal on the methodology that is used to rate insurance companies. Issue: Russian sanctions legislation. Issue: Request for information from Congress regarding the diversity and inclusion information in the insurance industry. Issue: National Association of Registered Agents and Brokers (NARAB) board. No bill number assigned. Issue: Housing Finance Reform. No bill number assigned. Issue: Final margin rules for uncleared swaps transactions with respect to seeded investment funds. No bill number assigned.

Client expense: $887,493 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Public Law 111-203, H.R. 4173- Dodd-Frank Wall Street Reform and Consumer Protection Act. Issue: Implementation and Regulatory reform. Captive Reinsurance Transactions, Insurance Capital Standards and Global Capital Standards. Implementation of S. 2270 - Insurance Capital Standards Clarification Act of 2014. The bill would give the Federal Reserve the authority to tailor capital standards for insurance companies subject to Fed supervision. Issue: Capital Standards, Basel III Implementation of H.R. 748 - the Coronavirus Aid, Relief, and Economic Security (CARES) Act. This bill responds to the COVID-19 (i.e., coronavirus disease 2019) outbreak and its impact on the economy, public health, state and local governments, individuals, and businesses. Issue: CECL, TDR, Remote Online Notarization, SBA loans. H.R. 2923/S. 1384 Living Donor Protection Act. The bill would promote and protect from discrimination living organ donors. Issue: underwriting. Issue: private equitys growing role in the insurance industry. Issue: S&P proposal on the methodology that is used to rate insurance companies. Issue: Russian sanctions legislation. Issue: Request for information from Congress regarding the diversity and inclusion information in the insurance industry. Issue: National Association of Registered Agents and Brokers (NARAB) board. No bill number assigned. Issue: Housing Finance Reform. No bill number assigned. Issue: Final margin rules for uncleared swaps transactions with respect to seeded investment funds. No bill number assigned.

Client expense: $980,852 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

INS - Quarter 2 2023 Public Law 111-203, H.R. 4173- Dodd-Frank Wall Street Reform and Consumer Protection Act. Issue: Implementation and Regulatory reform. Captive Reinsurance Transactions, Insurance Capital Standards and Global Capital Standards. H.R. 2923/S. 1384 Living Donor Protection Act. The bill would promote and protect from discrimination living organ donors. Issue: underwriting. Issue: private equitys growing role in the insurance industry. Issue: S&P proposal on the methodology that is used to rate insurance companies. Issue: Request for information from Congress regarding the diversity and inclusion information in the insurance industry. Issue: Housing Finance Reform. No bill number assigned.

Client expense: $720,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

INS - Quarter 2 2023 Public Law 111-203, H.R. 4173- Dodd-Frank Wall Street Reform and Consumer Protection Act. Issue: Implementation and Regulatory reform. Captive Reinsurance Transactions, Insurance Capital Standards and Global Capital Standards. H.R. 2923/S. 1384 Living Donor Protection Act. The bill would promote and protect from discrimination living organ donors. Issue: underwriting. Issue: private equitys growing role in the insurance industry. Issue: S&P proposal on the methodology that is used to rate insurance companies. Issue: Request for information from Congress regarding the diversity and inclusion information in the insurance industry. Issue: Housing Finance Reform. No bill number assigned.

Client expense: $580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA

Client expense: $1,902,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA

Client expense: $1,129,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA

Client expense: $1,631,812 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.1206 Medicare Drug Savings Act of 2011 H.R.2190 Medicare Drug Savings Act of 2011 Section 9008 of Patient Protection and Affordable Care Act Prescription Drug User Fee Act (PDUFA) H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA

Client expense: $1,918,136 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

HR 452 - Medicare Decisions Accountability Act of 2011 S 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Gene Therapy Personalized Medicine H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Public Health Service Act Dextromethorphan - Age Restrictions - Controlling bulk shipments Pseudoephedrine - Promote e-tracking; oppose Rx legislation FSA/HSA - Support reinstating coverage of OTC products Enhance supply and shipping parameters for beta-Propiolactone Support incentives for development of new, innovative antibiotics (former GAIN Act) MDUFA

Client expense: $1,650,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA

Client expense: $1,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

H.R. 1204, the Community Pharmacy Fairness Act of 2009 and S. 2191, the Community Pharmacy Fairness Act from the 110th Congress; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; H.R. 6331 (110th Congress), the Medicare Improvement for Patients and Providers Act of 2008-Sec. 172 related to the implementation of the Medciare Part D prompt pay requirements and submission of claims by pharmacies located in or contracting with long-term care facilities; H.R. 5235, the Medicare Access to Diabetic Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010-advocated for inclusion of the extension of the Federal Medicaid Matching Rate (FMAP) and limiting access to 340b drugs in outpatient settings to only eligible individuals in both House bill and Senate amendment; H.R. 5839 (110th Congress) the Safeguarding America's Pharmaceuticals Act of 2008, provisions related to pedigree and track and trace requirements-no bill introduced in the current Congress; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act , includes funding for the Department of Defense FY11 budget and covers the TRICARE pharmacy program; H.R. 3108 and S. 3543, the Medication Therapy Management Expanded Benefit Act; H.R. 2923, the Combat Meth Act of 2009; S. 1383, the Dextromethorphan Abuse Reduction Act of 2009; submitted comments to Senate Committee on Aging on prescription drug disposal and the role of nurses as agents in long-term care facilities; sought Congressional support to stop exclusion of certain retail pharmacies from "employee prescription drug plans;" worked with Congressional offices to request the FTC review the 180 day generic drug marketing exclusivity policies of certain generic manufacturers; sought Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); submitted comments to Senate Judiciary Committee regarding the FTC and DOJ antitrust oversight; submitted comments to Senate Homeland Security and Government Affairs Committee regarding a HHS OIG report, "Invalid Prescriber Identifiers on Medicare Part D Drug Claims;" FSA debit card program-seeking Congressional support to amend IRS guidance (no legislation).

Client expense: $106,568 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Treasury, Dept of

H.R. 1204, the Community Pharmacy Fairness Act of 2009 and S. 2191, the Community Pharmacy Fairness Act from the 110th Congress; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; H.R. 6331 (110th Congress), the Medicare Improvement for Patients and Providers Act of 2008-Sec. 172 related to the implementation of the Medciare Part D prompt pay requirements and submission of claims by pharmacies located in or contracting with long-term care facilities; H.R. 5235, the Medicare Access to Diabetic Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010-advocated for inclusion of the extension of the Federal Medicaid Matching Rate (FMAP) and limiting access to 340b drugs in outpatient settings to only eligible individuals in both House bill and Senate amendment; H.R. 5839 (110th Congress) the Safeguarding America's Pharmaceuticals Act of 2008, provisions related to pedigree and track and trace requirements-no bill introduced in the current Congress; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act , includes funding for the Department of Defense FY11 budget and covers the TRICARE pharmacy program; H.R. 3108 and S. 3543, the Medication Therapy Management Expanded Benefit Act; H.R. 2923, the Combat Meth Act of 2009; S. 1383, the Dextromethorphan Abuse Reduction Act of 2009; submitted comments to Senate Committee on Aging on prescription drug disposal and the role of nurses as agents in long-term care facilities; sought Congressional support to stop exclusion of certain retail pharmacies from "employee prescription drug plans;" worked with Congressional offices to request the FTC review the 180 day generic drug marketing exclusivity policies of certain generic manufacturers; sought Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); submitted comments to Senate Judiciary Committee regarding the FTC and DOJ antitrust oversight; submitted comments to Senate Homeland Security and Government Affairs Committee regarding a HHS OIG report, "Invalid Prescriber Identifiers on Medicare Part D Drug Claims;" FSA debit card program-seeking Congressional support to amend IRS guidance (no legislation).

Client expense: $106,568 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Treasury, Dept of

H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA

Client expense: $1,000,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals

Client expense: $715,571 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Office of Natl Drug Control Policy (NDCP), SENATE, Treasury, Dept of

- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetamine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.

Client expense: $850,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

**see addendum page Importation of prescription drugs (S.525/H.R. 1298) RX Pedigree Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923) Pharmacy Benefit Management Issues (H.R. 4489) Drug Disposal (S. 3397, H.R. 5809) PDMP Funding/NASPER reauthorization (H.R. 5710) Drug Safety Enhancement Act (H.R. 6543)

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 415, the "Fallen Heros Flag Act," would provide the families of deceased public safety officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 725, the "Indians Arts and Crafts Amendments Act," provides additional funding and training for tribal law enforcement officers; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695, the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; H.R. 4466, legislation amending the Hatch Act to allow local and State law enforcement officers to be candidates for the office of Sheriff and permit Sheriffs to engage in political activity; H.R. 6235/S. 3972, the "National Blue Alert," legislation creating an anlert system for law enforcement officers killed or seriously injured in the line of duty; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714/H.R. 5143, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office

S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2010 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 Under Line 17: We would like to include the Office of National Drug Control Policy (ONDCP) HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act S 80 - Pharmaceutical Market Access Act of 2009 HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA-2010-N-0001) Third Annual Sentinel Initiative Public Workshop (Docket Number: FDA-2010-N-0128) Prescription Drug User Fee Act; Reopening of the Comment Period (Docket Number: FRL-9197-7) EPA Best Management Practices for Unused Pharmaceuticals at Health Care Facilities (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: DEA-338) Schedules of Controlled Substances: Placement of Propofol Into Schedule IV; Proposed Rule (Docket Number: FDA-2010-N-0273) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Quality System Regulations (Docket No. FDA-2010-N-0344) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices and Radiation-Emitting Products (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: FDA-2010-N-0477) Approval Pathway for Biosimilar and Interchangeable Biological Products; Public Hearing; Request for Comments (Docket Number: FDA2010N0486) Safe Use Initiative; Public Workshop; Request for Comments (RIN 0720AB45) DoD Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE: Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals (Docket Number: DEA316N) Procedures for the Surrender of Unwanted Controlled Substances by Ultimate Users; Notice of Meeting (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies FDA Draft Guidance for Industry and Food and Drug Administration Staff on Dear Health Care Provider Letters: Improving Communication of Important Safety Information Concept Standardizing REMS programs, components and development of a potential tiered REMS System Concept 2010 National Drug Control Strategy (ONDCP)

Client expense: $240,240 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE, White House Office

Importation of prescription drugs (S. 525/H.R. 1298); Drug Safety Enhancement Act (H.R. 6543); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues (H.R. 4489); Drug Disposal (S. 3397, H.R. 5809); PDMP Funding/NASPER Reauthorization (H.R. 5710)

Client expense: $214,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 415, the "Fallen Heros Flag Act," would provide the families of deceased public safety officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 725, the "Indians Arts and Crafts Amendments Act," provides additional funding and training for tribal law enforcement officers; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695, the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; H.R. 4466, legislation amending the Hatch Act to allow local and State law enforcement officers to be candidates for the office of Sheriff and permit Sheriffs to engage in political activity; H.R. 6235, the "National Blue Alert," legislation creating an anlert system for law enforcement officers killed or seriously injured in the line of duty; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714/H.R. 5143, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office

- H.R. 1259, "To amend the Federal Food, Drug, and Cosmetic Act with respect to the distribution of the drug dextromethorphan, and for other purposes", regarding all provisions. - H.R. 1346 / S. 540, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices", regarding all provisions. - S. 1142, "A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to inclusion of effectiveness information in drug and device labeling and advertising", regarding all provisions. - H.R. 2502, "To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes", regarding all provisions. - S. 882, "A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety and quality of medical products and enhance the authorities of the Food and Drug Administration, and for other purposes", regarding all provisions. - S. 1383, "A bill to amend the Controlled Substances Act to prevent the abuse of dextromethorphan, and for other purposes", regarding all provisions. - Issues relating to the McNeil recall of over the counter medications. - H.R. 2923, "A bill to Enhance the ability to combat Methamphetimine", regarding all provisions. - H.R. 5786, "Safe Cosmetics Act of 2010", regarding all provisions.

Client expense: $2,410,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals

Client expense: $736,734 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Office of Natl Drug Control Policy (NDCP), SENATE

H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA

Client expense: $1,842,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2009 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting on Opioid REMS (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies DEA National Drug Take-Back Day Concept Standardizing REMS programs, components and development of a potential tiered REMS System

Client expense: $212,859 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

**see addendum page Importation of prescription drugs (S.525/H.R. 1298) RX Pedigree Import Safety (H.R. 759) Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923)) Pharmacy Benefit Management Issues (H.R. 4489) Drug Disposal (S. 3397, H.R. 5809) PDMP Funding/NASPER reauthorization (H.R. 5710)

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Importation of prescription drugs (S. 525/H.R. 1298); House Energy and Commerce Committee discussion draft; Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues (H.R. 4489); Drug Disposal (S. 3397, H.R. 5809); PDMP Funding/NASPER Reauthorization (H.R. 5710)

Client expense: $270,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1204, the Community Pharmacy Fairness Act of 2009 and S. 2191, the Community Pharmacy Fairness Act from the 110th Congress; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; H.R. 6331 (110th Congress), the Medicare Improvement for Patients and Providers Act of 2008-Sec. 172 related to the implementation of the Medciare Part D prompt pay requirements and submission of claims by pharmacies located in or contracting with long-term care facilities; H.R. 5235, the Medicare Access to Diabetic Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010-advocated for inclusion of the extension of the Federal Medicaid Matching Rate (FMAP) and limiting access to 340b drugs in outpatient settings to only eligible individuals in both House bill and Senate amendment; H.R. 5839 (110th Congress) the Safeguarding America's Pharmaceuticals Act of 2008, provisions related to pedigree and track and trace requirements-no bill introduced in the current Congress; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act , includes funding for the Department of Defense FY11 budget and covers the TRICARE pharmacy program; H.R. 3108 and S. 3543, the Medication Therapy Management Expanded Benefit Act; H.R. 2923, the Combat Meth Act of 2009; S. 1383, the Dextromethorphan Abuse Reduction Act of 2009; submitted comments to Senate Committee on Aging on prescription drug disposal and the role of nurses as agents in long-term care facilities; sought Congressional support to stop exclusion of certain retail pharmacies from "employee prescription drug plans;" worked with Congressional offices to request the FTC review the 180 day generic drug marketing exclusivity policies of certain generic manufacturers; sought Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); submitted comments to Senate Judiciary Committee regarding the FTC and DOJ antitrust oversight; submitted comments to Senate Homeland Security and Government Affairs Committee regarding a HHS OIG report, "Invalid Prescriber Identifiers on Medicare Part D Drug Claims;" FSA debit card program-seeking Congressional support to amend IRS guidance (no legislation).

Client expense: $106,568 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Treasury, Dept of

H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA

Client expense: $1,616,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

HR 1259 & S 1383 - Dextromethorphan Abuse S. 256 & HR 2923 - Methamphetamine Abuse Issues related to methamphetamine precursor chemicals

Client expense: $1,687,444 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE

H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695, the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; H.R. 4466, legislation amending the Hatch Act to allow local and State law enforcement officers to be candidates for the office of Sheriff and permit Sheriffs to engage in political activity; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714/H.R. 5143, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office

Importation of prescription drugs (S.525/H.R. 1298); Import Safety (H.R. 759); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues - (H.R. 4489); Drug Disposal

Client expense: $220,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695, the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; H.R. 4466, legislation amending the Hatch Act to allow local and State law enforcement officers to be candidates for the office of Sheriff and permit Sheriffs to engage in political activity; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714/H.R. 5143, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office

HR 1259 & S 1383 - Dextromethorphan Abuse S. 256 & HR 2923 - Methamphetamine Abuse

Client expense: $423,644 · Firm income: Not reported

Government targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE

H.R.3200 America's Affordable Health Choices Act of 2009 S.1796 America's Healthy Future Act of 2009 H.R.3962 Affordable Health Care for America Act H.R.3590 Patient Protection and Affordable Care Act H.R.4872 Health Care and Education Reconciliation Act of 2010 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 H.R.759 Food and Drug Administration Globalization Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy PDUFA

Client expense: $2,040,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)

HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse

Client expense: $422,034 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE

Vaccines for Children Program Vaccines for Adults Coverage Provide Medicare Part B Coverage for Vaccines Currenlty Under Part D Medicaid Coverage of Vaccines HR 3200 America's Affordable Health Choices Act of 2009 HR 2502 Comparative Effectiveness Research Act of 2009 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension

Client expense: $1,570,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)

H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2221, Data Accountability and Trust Act, related to the use of prescription drug data by pharmacies. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. 3108, the Medication Therapy Management Benefits Act, as related to an expanded MTM program in the Medicare Part D program. H.R. 3200, America's Affordable Health Choices Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. H.R. 3590, Patient Protection and Affordable Care Act, as related to the role of pharmacy in healthcare reform, specifically related to Medicare and Medicaid issues. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME Program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically related to Medicare and Medicaid issues. S.1383, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.

Client expense: $450,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

H.R. 18, the Powder-Crack Cocaine Penalty Equalization Act, would eliminate the disparity in sentencing between crack and powder cocaine offenses by changing the applicable amounts for powder cocaine to those currently applicable to crack cocaine; H.R. 73, the Traffic Stops Along the Border Statistics Study Act, would require the U.S. Attorney General to collect race and other data on traffic stops made by State and local law enforcement officers; H.R. 248, the Law Enforcement Officers Flag Memorial Act, would provide the families of deceased law enforcement officers with a flag that has been flown over the U.S. Capitol; H.R. 675, legislation which would grant statutory arrest authority to law enforcement officers employed by the U.S. Department of Defense; H.R. 1006/S. 418, the Secondary Metal Theft Prevention Act, would require secondary metal recycling agents to keep records of their transactions in order to deter individuals and enterprises engaged in the theft and interstate sale of stolen secondary metal; H.R. 1459, the Fairness in Cocaine Sentencing Act, would eliminate the increased and mandatory minimum sentences for drug offenses involving crack cocaine as well as repeal the existing restrictions on the court to grant probation or suspended sentences for drug offenses involving cocaine; H.R. 1913/S. 909, the "Local Law Enforcement Hate Crimes Prevention Act," which would would expand current Federal hate-crimes law, which covers the use or threat of force based on race, color, religion or national origin, to crimes committed against victims because of their sexual orientation, gender or gender identity; H.R. 2064/S. 879, the See Something, Say Something Act, would expand the current immunity from liability to cover all persons who report suspicious activity to authorities, not just suspicious activity which occurs on Federal property or transportation systems; H.R. 2923/S. 256, the Combat Methamphetamine Enhancement Act, will strengthen Federal law by improving the self-certification process for retail sales of ephedrine and pseudoephedrine; H.R. 3245, the Fairness in Cocaine Sentencing Act, which would remove references to cocaine base from the U.S. Code, thereby greatly reducing the sentences of offenders convicted for offenses involving crack cocaine; H.R. 3695 (Murphy, D-CT), the Help Find the Missing Act, would authorize the National Missing Persons and Unidentified Persons System (NamUs) at the U.S. Department fo Justice and connect it wth the Crime Information Center maintained by the Federal; Bureau of Investigation; S. 132, the Gang Abatement and Prevention Act, is a comprehensive, national approach to the problem of gang violence which would establish a High Intensity Interstate Gang Activity Area (HIIGAA) program to facilitate greater cooperation between local, State and Federal law enforcement in identifying, targeting, and eliminating violent gangs in areas where gang activity is particularly prevalent and define new offenses which will enable law enforcement to fight gangs and gang-related activity more effectively; S. 258, the Saving Kids from Dangerous Drugs Act, would increase penalties on those who tailor-market illegal drugs to entice children to purchase them; S. 386, the Fraud Enforcement and Recovery Act, which would strengthen the ability of law enforcement to investigate and prosecute fraudulent activity in connection with bailout and recovery legislation; S. 569, the Incorporation Transparency and Law Enforcement Assistance Act,would help law enforcement combat the misuse of U.S. corporations by requiring States to obtain beneficial ownership information for corporations and limited liability companies formed under State law; S. 714, the National Criminal Justice Commission Act," which would create a National Commission to examine the U.S. criminal justice systems at the State and Federal level; S. 1039, the Protect Those Who Serve Act, which would authorize up to $500 million in grants to States to provide up to eighty percent (80%) of the costs of the renovatio, .modernization, and construction of law enforcement facilities; H.R. 3752/S. 1132, the Law Enforcement Officers Safety Act Improvements Act, would improve the provisions related to carriage of concealed firearms by qualified active and retired law enforcement officers; S. 1147, the Prevent All Cigarette Trafficking Act, which would assist local, State and Federal law enforcement in combating cigarette smuggling; S. 1261, the "Providing for Additional Security in States' Identification (PASS ID) Act," which would repeal the REAL ID Act of 2005; S. 1789, the Fair Sentencing Act, would abolish the mandatory minimum for possession of crack cocaine and substantially reduce the penalties for other crack cocain offenses; S. 2885, the First Responders Support Act, which would amend the Public Safety Officers Benefits (PSOB) program by increasing the disability benefit, the Public Safety Officers Educational Assistance benefit, prioritize the handling of all PSOB claims and provide free or reduce cost mental health services and counseling to family members of public safety officers who are severely injured or killed in the line of duty; and Opposition to legislation which would normalize relations with Cuba until that nation ceases to be a safe harbor for cop-killers and other fugitives.

Client expense: $55,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, Veterans Affairs, Dept of (VA), White House Office

HR 1259 & S 1383 - Dextromethorphan Abuse S 256 & HR 2923 - Methamphetamine Abuse

Client expense: $225,686 · Firm income: Not reported

Government targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE

Vaccines for Children Program Vaccines for Adults Coverage Provide Medicare Part B Coverage for Vaccines Currenlty Under Part D Medicaid Coverage of Vaccines HR 3200 America's Affordable Health Choices Act of 2009 HR 2502 Comparative Effectiveness Research Act of 2009 S 75 - Generics First Act 2009 S 301 - Physician Payments Sunshine Act of 2009 HR 276 - Proper Disposal of Unused Pharmaceuticals S1213 Patient-Centered Outcomes Research Act of 2009 HR 4702, HR 4990 - A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. HR 4705 HR 4993, S 2466 - Vaccines for the uninsured Adult Act of 2008 S 2467 - Vaccine shortage preparedness Act of 2008 S 3678 - /PL 109-417 All pandemic and all-hazards act - Section 317 program issues HR 1259 Dextromethorphan Distribution Act of 2009 S 1383 Dextromethorphan Abuse Reduction Act of 2009 S 256 Combat Methamphetamine Enhancement Act of 2009 HR 2923 Combat Methamphetamine Enhancement Act of 2009 HR 1038, S623 - Access to Life-Saving Medicine Act HR 1548 Pathway for Biosimilars Act HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act S 726 - Promoting Innovation and Access to Life-Saving Medicine Act S.1232 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 1548 - To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 21st Century Cancer Bill Personalized Medicine Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension

Client expense: $1,420,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)

H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. 3108, the Medication Therapy Management Benefits Act, as related to an expanded MTM program in the Medicare Part D program. H.R. 3200, America's Affordable Health Choices Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME Program. S.1383, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan. S.___, Americas Healthy Future Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. Various issues related to the role of pharmacy and pharmacists in healthcare reform, including pharmacy services in the Medicare program.

Client expense: $720,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office